Paulson Investment Company Research
Overview
Paulson Investment Company, LLC is a highly esteemed boutique investment banking firm founded in 1970 in Portland, Oregon. For over 55 years, the firm has established itself as a premier advisor focused on the small to mid-cap markets, specializing in capital markets solutions and investment banking services. With offices in Portland, New York, Beverly Hills, San Francisco, Chicago, St. Petersburg, Fort Lauderdale, Memphis, New Jersey, Lake Mary, and Newport Beach, Paulson operates a truly national platform dedicated to helping clients achieve their strategic and financial objectives.
Sector Focus and Specialization
Paulson Investment Company concentrates its advisory practice on Life Sciences, Technology, and Media sectors. Within these sectors, the firm has developed deep expertise:
Life Sciences & Healthcare: The firm maintains a robust healthcare investment banking team, including a dedicated Healthcare Investment Banking practice. Donald Wojnowski, Senior Managing Director with over 40 years of healthcare banking experience, leads this vertical. Jainal Bhuiyan, also a Senior Managing Director, brings deep healthcare and value investing expertise from his prior work at HRA Capital and Provident Healthcare Partners. The firm has extensive experience advising on biotech company financings, pharmaceutical capital raises, and healthcare services transactions.
Technology: Marta Wypych, Head of Investment Banking with 15+ years of experience, oversees the firm's technology practice. The firm has advised on software, SaaS, IT services, and hardware/electronics capital raises and strategic transactions.
Media & Communications: The firm also maintains active practices in media, entertainment, and communications sector advisory work.
Transaction History and Deal Volume
Paulson Investment Company has participated in over 175 public and private offerings, representing substantial transaction experience. Since 2014, the firm has been actively involved in more than 175 transactions and has raised approximately $1.2 billion in capital for client companies. The transactions list on their website documents extensive placement agent and capital raising work across biotech, pharmaceutical, medical device, software, and specialty sector companies.
Recent and notable transaction experience includes:
- Placement agent roles on numerous biotech capital raises (Cresilon, CytoDyn, Akari Therapeutics, Indaptus Therapeutics, TuHURA Biosciences)
- Healthcare advisory roles on strategic transactions
- Capital raises ranging from $1.5M to $100M+
- Work across public and private companies, including NASDAQ-listed firms
Advisory Profile and Approach
Sweet Spot: Private growth-stage and public companies in Life Sciences, Technology, and Media sectors seeking strategic capital raises, private placement solutions, and comprehensive investment banking advisory.
Thesis: Paulson believes that successful growth capital transitions require expertise across capital markets mechanics, regulatory compliance, investor relations, and strategic positioning. The firm's approach combines institutional-quality process management with sector-specific expertise to deliver superior outcomes for clients.
Process: Paulson's investment banking team combines strategic advising with execution expertise. The firm manages placement processes, structures complex capital transactions, coordinates with institutional and strategic investors, and leverages its national network to achieve optimal outcomes. Engagements typically involve comprehensive market analysis, investor targeting, documentation preparation, and transaction management through close.
Team and Management
Paulson's leadership team brings combined 100+ years of investment banking and financial services experience:
Executive Management:
- Trent Davis, Chief Executive Officer (28+ years in capital markets, formerly CEO 2005-2014, oversaw $600M in syndications)
- Chris Clark, Chairman of the Board (34+ years, former Senior Managing Director at Lehman Brothers and Black & Co.)
- Thomas Parigian, Senior Managing Partner (35+ years, $500M+ raised, specialized pharma fundraising)
- Robert Setteducati, Managing Partner / Director of Business Development (36+ years capital raising experience)
- Alex Winks, President and Chief Financial Officer (17+ years in broker/dealer and RIA operations)
Investment Banking Leadership:
- Marta Wypych, Head of Investment Banking (15+ years, Series 7, 24, 63, 79 licenses)
- Donald A. Wojnowski, Senior Managing Director, Healthcare Investment Banking (40+ years, Series 3, 7, 24, 63, 66, 79 licenses)
- Jainal Bhuiyan, Senior Managing Director (Healthcare and value investing focus, Series 7, 63, 79 licenses)
Geographic Presence and Operations
Paulson operates from 10 strategic office locations across the United States: Portland, Oregon (headquarters); New York; Beverly Hills; San Francisco; Chicago; St. Petersburg; Fort Lauderdale; Memphis; New Jersey; and Lake Mary. This geographic footprint provides nationwide coverage and local market expertise across major financial and technology hubs.
FINRA Registration and Regulatory Status
Paulson Investment Company, LLC is a fully registered broker-dealer with the Financial Industry Regulatory Authority (FINRA), holding CRD# 5670 and SEC# 801-107194. The firm maintains all required licenses and registrations for its investment banking operations. A team of FINRA-registered brokers and investment bankers holds appropriate Series 7, 24, 63, 66, and 79 securities licenses, reflecting depth of regulatory compliance and professional credentials.
Recent Strategic Evolution
In February 2024, Paulson Capital Holding Company (parent of Paulson Investment Company) completed the acquisition of Orca Investment Management, LLC, an investment advisory firm managing approximately $190 million in assets. This acquisition enhanced the firm's capabilities to deliver comprehensive wealth management services alongside investment banking advisory.
In October 2025, Paulson acquired JWTT, Inc., a specialized investment bank and broker-dealer focused on community banking. JWTT brings deep sector expertise and $470 million in customer assets, expanding Paulson's advisory platform.
Competitive Positioning
Paulson differentiates through:
- Sector expertise in high-growth life sciences, technology, and media (vs. generalist banks)
- Deep investor relationships (institutional, strategic, and family office networks)
- Capital markets execution expertise (not just advisory, but integrated capital raise capability)
- National platform with local market presence
- Management team with 25-40 years of individual experience
- Full broker-dealer capabilities enabling transaction execution
Capital Raising and Investment Banking Services
Unlike traditional M&A advisors focused on sell-side and buy-side advisory, Paulson operates as an integrated capital markets firm providing:
- Placement agent services for private equity offerings
- Equity capital raise advisory (common stock, preferred stock, convertible securities)
- Debt financing solutions
- Strategic investor introductions
- Securities underwriting and syndication
- Corporate finance advisory
Time Horizon and Process
Capital raise engagements typically require 3-6 months from engagement through closing. The firm manages institutional-quality processes including investor targeting, management presentation support, due diligence coordination, and transaction documentation.
Ideal Client Profile
Ideal clients for Paulson are:
- Growth-stage and mature private companies in life sciences, tech, or media
- Public companies seeking secondary offerings or strategic capital
- Biotech and pharmaceutical firms requiring multiple capital raises
- Management teams seeking expansion capital or recapitalization
- Companies targeting strategic or financial investor networks
Competitive Positioning vs. Alternatives
Versus other capital markets firms, Paulson offers the advantage of healthcare sector specialization combined with technology and media expertise. Unlike large bulge-bracket banks that may de-prioritize small-to-mid cap placements, Paulson dedicates senior managing director-level attention to every transaction.